The estimated Net Worth of Steven R Altman is at least 35.5 百万$ dollars as of 16 January 2024. Mr. Altman owns over 1,568 units of Dexcom Inc stock worth over 3,637,948$ and over the last 17 years he sold DXCM stock worth over 31,569,801$. In addition, he makes 324,596$ as Independent Director at Dexcom Inc.
Steven has made over 120 trades of the Dexcom Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently he sold 1,568 units of DXCM stock worth 192,644$ on 16 January 2024.
The largest trade he's ever made was exercising 284,436 units of Dexcom Inc stock on 28 August 2012 worth over 10,222,630$. On average, Steven trades about 33,729 units every 38 days since 2008. As of 16 January 2024 he still owns at least 53,132 units of Dexcom Inc stock.
You can see the complete history of Mr. Altman stock trades at the bottom of the page.
Steven R. Altman serves as Independent Director of the Company. He has served on our Board since November 2013. From November 2011 through January 2014, Mr. Altman served as the vice chairman of Qualcomm Incorporated (“Qualcomm”) and a member of Qualcomm’s Executive Committee. Mr. Altman previously served as the president of Qualcomm from July 2005 to November 2011, as Executive Vice President from November 1997 to June 2005 and as President of Qualcomm Technology Licensing from September 1995 to April 2005. Mr. Altman was the chief architect of Qualcomm’s strategy for licensing its broad intellectual property portfolio for wireless communications, which has accelerated the growth of CDMA technology. Mr. Altman received a B.S. from Northern Arizona University in Police Science and Administration and a J.D. from the University of San Diego.
As the Independent Director of Dexcom Inc, the total compensation of Steven Altman at Dexcom Inc is 324,596$. There are 12 executives at Dexcom Inc getting paid more, with Kevin Sayer having the highest compensation of 10,279,400$.
Steven Altman is 58, he's been the Independent Director of Dexcom Inc since 2013. There are 13 older and 15 younger executives at Dexcom Inc. The oldest executive at Dexcom Inc is Andrew K. Balo, 73, who is the Exec. VP of Regulatory Strategy, Clinical Affairs & Strategic Partnership Devel..
Steven's mailing address filed with the SEC is 6340, Sequence Drive, Sorrento Valley, San Diego, San Diego County, California, 92121, United States.
Over the last 19 years, insiders at Dexcom Inc have traded over 724,717,982$ worth of Dexcom Inc stock and bought 165,450 units worth 3,489,100$ . The most active insiders traders include Sean Carney、Kim D Blickenstaff、Steven R Altman. On average, Dexcom Inc executives and independent directors trade stock every 7 days with the average trade being worth of 892,438$. The most recent stock trade was executed by Sadie Stern on 9 September 2024, trading 426 units of DXCM stock currently worth 29,458$.
founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.
Dexcom Inc executives and other stock owners filed with the SEC include: